Soley Therapeutics (Series C)
Funding Details
Awarder
RSS - feeds.feedburner.com
Date Award
January 12, 2026
Vertical
Biotechnology
Funding Amount
$200,000,000
Company Info
Market
Oncology and Neurodegenerative Disorders
Location
South San Francisco, California, USA
Coinvestors
Surveyor Capital, HRTG Partners, RWN Management, Doug Leone Family Fund, Breyer Capital, GordonMD Global Investment LP
Company Description

Soley Therapeutics is advancing its proprietary cell stress sensing platform and pipeline of novel therapeutics into the clinic, focusing on oncology and neurodegenerative disorders.

Links